Webinar: Improving Forecast Accuracy for High-Cost Oncology Medicines – What NHS Oncology Pharmacy Operations Reveal About Real-World Utilisation

Webinar

24 Jun

Written By Verpora

Access to this On Demand webinar and its related report
is by request only. Click here to request access.

Forecasting models account for clinical and epidemiological drivers of oncology medicine demand. However, NHS operational pharmacy processes also determine how medicines are delayed, reduced, shared, compounded, and wasted in practice, often creating meaningful gaps between forecasted and observed utilisation.

Drawing on new primary market research conducted with senior NHS oncology pharmacy professionals across major oncology centres in England, this webinar explores the internal operational processes behind oncology medicines handling, and the impact each has on forecasting assumptions and real-world utilisation patterns.

Hosted by Verpora alongside NHS contributors involved directly in the research, the session will unpack how dose banding, treatment delays, dose reductions, vial sharing, compounding pathways, and wastage influence observed utilisation, and share practical recommendations for improving forecasting assumptions.

If your remit includes forecasting, interpreting oncology utilisation data, or understanding variability in observed medicine usage, this webinar will provide:

Clearer understanding of how internal NHS operational processes influence real-world utilisation patterns
Practical insight into the operational factors driving divergence between forecasted and observed utilisation
Better context for interpreting dose banding, vial sharing, treatment delays, dose reductions, and wastage within utilisation datasets
Greater confidence in pressure-testing forecasting assumptions and patient-to-volume conversion models
Frontline perspectives from NHS oncology pharmacy professionals involved directly in medicines handling and operational delivery

Request the report & webinar access

To request your copy of the report and a pass code to view this webinar, please complete the form below.

Please note that we only grant access to requests from professional work email domains.‍ ‍

Combining analysis from the Verpora team with practical interpretation from NHS oncology pharmacy professionals who contributed directly to the research interviews, the full report explores:

How dose banding changes medicine usage and vial assumptions
Why treatment delays and dose reductions materially alter observed utilisation
How vial sharing impacts wastage and patient-to-volume conversion
The operational realities behind internal vs external compounding
Why wastage assumptions vary significantly between products and NHS Trusts
How frontline NHS operational insight complements utilisation datasets and forecasting models

Preview image of the Oncology Medicines Handling report, and two inside pages with charts and infographics

Webinar Disclaimer: This presentation is for discussion purposes only. No part of this presentation is intended as legal advice. This presentation is based on non-confidential, publicly sourced intelligence. Views expressed by the speakers are personal opinion and should not be attributed to anyone else. No part of this webinar may be reproduced for commercial purposes without the express permission of Verpora and Manatt Health.